Vitiligo (Dutch: Vitiligo) is an autoimmune skin disease characterized by the loss of melanocytes, the cells responsible for producing pigment in the skin, hair, and mucous membranes. This results in white or depigmented patches on various areas of the body.
The term "vitiligo" comes from the Latin vitium, meaning "blemish," and lexis, "mark." It was first described in medical literature by Galen, a Greek physician, around 160 AD.
Vitiligo affects approximately 1% of the global population regardless of age, sex, or ethnicity. It can manifest at any age but is most commonly diagnosed between ages 10 and 30.
The exact cause of vitiligo remains unknown, but it's believed to be an autoimmune condition where the immune system mistakenly attacks the melanocytes. Factors such as family history, stress, sunburn, and exposure to certain chemicals may trigger its onset.
There are three primary types of vitiligo: segmental vitiligo, non-segmental vitiligo (generalized or localized), and acrofacial vitiligo. Segmental vitiligo affects only one side or half of the body, while non-segmental vitiligo can appear anywhere and may develop gradually or quickly. Acrofacial vitiligo primarily affects the extremities and mucous membranes.
While vitiligo itself is not painful or life-threatening, it can lead to emotional distress due to its visual impact. Sun sensitivity is also common among affected individuals, making them prone to sunburns and other skin issues. In some cases, patients may develop a condition called susceptibility to freezing temperatures (Koebner phenomenon), causing white spots to appear after exposure to cold weather or traumatic skin injury.
A dermatologist typically diagnoses vitiligo based on its appearance and medical history. Wood's lamp examination-a special ultraviolet light source-may be used to help visualize the white patches better. Skin biopsy may rarely be necessary to confirm the diagnosis.
No known cure exists for vitiligo, but various treatments can help manage its symptoms: